Bidens pilosa

Bidens pilosa is a tropical plant containing bioactive flavonoids like quercetin and luteolin that support glucose metabolism through enhanced insulin sensitivity. Clinical studies demonstrate significant improvements in blood sugar control and beta cell function in diabetic patients.

Origin & History

Bidens pilosa is an annual herbaceous plant from the Asteraceae family, native to tropical America but now widely naturalized across tropical and subtropical regions globally. It is typically processed as an aqueous infusion, ethanol extract, or powdered form from the whole plant, containing flavonoids, polyphenols, and other phytochemicals that contribute to its antioxidant properties.

Historical & Cultural Context

Bidens pilosa has been used in traditional medicine systems across tropical America, Africa, and Asia for immune-related disorders, inflammatory conditions, and infections. Traditional applications include treatment of hepatitis, laryngitis, headaches, digestive issues, and chronic inflammatory conditions.

Health Benefits

• Blood sugar management: Pilot study (n=14) showed significant reductions in fasting blood glucose (201.7 to 123.3 mg/dL, p=0.048) and HbA1c (9.1% to 7.2%, p=0.033) in diabetic patients
• Beta cell function support: Safety pilot (n=7) demonstrated increased serum insulin and improved HOMA-β scores in healthy volunteers
• Liver protection: Preclinical rat studies (PMID 30394117) showed protection against CCl4-induced hepatotoxicity
• Antioxidant activity: In vitro studies demonstrated protection of red blood cells from AAPH-induced hemolysis and oxidative damage
• Immune modulation: Laboratory evidence shows modulation of cytokine production (TNF, IL-6, IL-1β, IL-8) in immune cells

How It Works

Bidens pilosa's flavonoids, particularly quercetin and luteolin, enhance glucose uptake by activating GLUT4 transporters and improving insulin receptor sensitivity. The compounds also stimulate pancreatic beta cells to increase insulin secretion while reducing hepatic glucose production through inhibition of gluconeogenesis enzymes.

Scientific Research

Human clinical evidence is limited to one pilot study (non-randomized, open-label) in 14 diabetic patients showing significant glucose and HbA1c reductions, and a safety pilot in 7 healthy volunteers demonstrating no toxicity over 3 months. Most supporting evidence comes from preclinical studies, including rat hepatoprotection research (PMID 30394117) and a poultry field trial for infection control (PMID 27098674).

Clinical Summary

A pilot study of 14 diabetic patients showed significant reductions in fasting glucose from 201.7 to 123.3 mg/dL (p=0.048) and HbA1c from 9.1% to 7.2% (p=0.033). A separate safety pilot with 7 participants demonstrated increased serum insulin levels and improved HOMA-β scores indicating better beta cell function. However, these are small preliminary studies requiring larger randomized controlled trials for confirmation. Current evidence suggests promise but remains limited due to small sample sizes.

Nutritional Profile

Bidens pilosa is a nutrient-dense leafy herb with documented bioactive composition. Macronutrients: leaves contain approximately 20-25% protein (dry weight basis), 5-8% crude fat, and 40-50% carbohydrates with notable fiber content (~15-20% crude fiber). Micronutrients: rich in calcium (~1,200-1,800 mg/100g dry weight), iron (~50-80 mg/100g dry weight), magnesium, potassium, and zinc; vitamin C content reported at 150-200 mg/100g fresh weight; beta-carotene (provitamin A precursor) present at significant levels (~8-12 mg/100g dry weight). Key bioactive compounds: (1) Polyacetylenes — particularly phenylheptatriyne (PHT) and other C13 polyacetylenes, identified as primary antimicrobial and anti-inflammatory agents; (2) Flavonoids — quercetin, luteolin, butein, okanin, and cytopiloyne (a novel polyacetylenic glucoside specific to this species, linked to beta-cell stimulation and blood glucose modulation, detected at ~0.1-0.5% dry weight in leaves); (3) Phenolic acids — caffeic acid, chlorogenic acid, and protocatechuic acid contributing to antioxidant and hepatoprotective activity; (4) Triterpenes — oleanolic acid and ursolic acid with hepatoprotective and anti-inflammatory roles; (5) Phytosterols including beta-sitosterol. Bioavailability notes: cytopiloyne and flavonoids show moderate oral bioavailability enhanced by traditional aqueous extraction (tea/decoction preparation); fat-soluble compounds (beta-carotene, phytosterols) benefit from co-consumption with dietary fat; iron bioavailability may be limited by co-occurring tannins but vitamin C content partially offsets this inhibition.

Preparation & Dosage

Clinically studied dosage: 400 mg of Bidens pilosa formulation (probetacell) taken orally three times daily (total 1200 mg/day) for 3-7 months showed blood sugar benefits. No standardization for active compound content has been established in human studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cinnamon, Chromium, Alpha-lipoic acid, Bitter melon, Gymnema sylvestre

Safety & Interactions

Bidens pilosa is generally well-tolerated with no serious adverse events reported in clinical trials. However, it may enhance the effects of diabetes medications, potentially causing hypoglycemia when combined with insulin or sulfonylureas. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with known allergies to plants in the Asteraceae family should exercise caution as cross-reactions may occur.